Medical Technology

@xconomy.com 3 years ago

Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More

@xconomy.com 4 years ago

Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

@xconomy.com 5 years ago

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

@xconomy.com 5 years ago

Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More

@xconomy.com 5 years ago

ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On

@xconomy.com 5 years ago

ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More

@xconomy.com 5 years ago

Six Life Science Firms Close Q3 with an IPO, More Are on the Way